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ABSTRACT
PURPOSE: To evaluate the effects of metoclopramide on metalloproteinases (MMP) and interleukins (IL) gene expression in colonic 
anastomoses in rats.
METHODS: Eighty rats were divided into two groups for euthanasia on the 3rd or 7th postoperative day (POD), then into two subgroups 
for sepsis induction or not, and then into subgroups to receive either metoclopramide or saline solution. Left colonic anastomosis were 
performed and then analyzed. 
RESULTS: On the 3rd POD, metoclopramide was associated with increased expression of MMP-1a, MMP-13, and TNF-α. On the 7th 
POD, the transcripts of all MMPs, TNF-α, IL-1β, IFN-γ, and IL-10 of the treated animals became negatively modulated. In the presence 
of sepsis, metoclopramide did not change MMPs and decreased IL-6, IL-1β, IFN-γ and IL-10 gene expression on the 3rd POD. On the 
7th POD, increased expression of all MMPs, IFN-γ and IL-10 and negative modulated TNF-α and IL-6 gene expression.
CONCLUSION: Administration of metoclopramide increased metalloproteinases and interleukins gene expression on the 3rd 
postoperative day and negatively modulated them on the 7th POD. In the presence of abdominal sepsis, metoclopramide did not change 
MMPs and decreased ILs gene expression on the 3rd POD. On the 7th POD, the drug increased expression of all MMPs.
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Introduction 
Anastomotic dehiscence is the most severe complication 
of colorectal surgery, occurring in 2.4 to 3.8% of the cases1. 
Different parameters can be used to analyze the healing 
process of anastomosis. Matrix metalloproteinases (MMPs) are 
a family of at least 20 zinc-dependent endopeptidases involved 
in the degradation of extracellular matrix components. MMP-1, 
MMP-8 and MMP-13 are collagenases and cleave types I and III 
collagen fibrils2. An increased presence of active forms of MMPs 
may lead to localized matrix degradation and a transient loss of 
strength in the anastomosed segment, thus leading to anastomotic 
dehiscence3. 
Another important healing parameter is cytokine 
expression in the anastomotic area. Several authors have assessed 
cytokine levels in the postoperative period and their relationship 
to anastomotic complications4-7. During the healing process, 
cytokines and chemokines interact to determine the strength of 
the inflammatory response and the extent of subsequent adhesion 
formation8. These interactions are complex and produce both pro- 
and anti-inflammatory cytokines. Pro-inflammatory cytokines 
include tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6 
and IL-8, while anti-inflammatory molecules include IL-4 and IL-
10.  
Many experimental studies have been carried out to 
assess colonic anastomotic healing and factors contributing 
to anastomotic failure, such as fecal contamination and drug 
administration8. Metoclopramide (methoxy-2-chloro-5-
procainamide) is an antiemetic prokinetic agent that stimulates 
gastrointestinal motility and has been used to treat paralytic ileus 
and to control postoperative vomiting.  
The aim of this study was to evaluate the effects of 
metoclopramide on MMP and IL gene expression in left colonic 
anastomoses in rats with or without induced abdominal sepsis.
Methods
The study was approved by the Animal Ethics Committee 
(AEC) of the Institute of Biological Sciences of Universidade de 
Brasília (UnB), protocol no. 67336/2009, Brazil. All procedures 
were carried out in accordance with the Brazilian guidelines for 
use of animals in research. 
Eighty healthy male Wistar rats (Rattus norvergicus) 
aged 90 to 120 days were used in the study. Throughout the 2-week 
preoperative period, the animals were housed in cages with five 
animals each and kept under a standard 12:12-hour artificial light/
dark cycle. Animals were fed standard chow and water ad libitum. 
There was no preoperative fasting period.
Experimental protocol
The rats were randomly divided into two groups of 40 
animals each for euthanasia on the 3rd or 7th postoperative day 
(POD). Further randomization was performed, and the animals 
were divided into subgroups of 20 rats each for sepsis induction or 
not (sepsis/no sepsis), and then into subgroups of 10 rats each to 
receive either metoclopramide or saline solution (Figure 1).
FIGURE 1 - Allocation of animals to groups and subgroups.
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General anesthesia was performed with xylazine 
hydrochloride (10 mg/kg) and ketamine hydrochloride (75 mg/
kg) administered intramuscularly. All surgical procedures were 
performed by the same surgeon.
The surgical site was shaved and disinfected with 
povidone-iodine. Clean, non-sterile surgical instruments were 
used. A 4.0-cm midline laparotomy incision was made, starting 
1.0 cm above the external genitalia. The distal colon was exposed, 
and a 0.5-cm segment of the left colon (2.5 to 3.0 cm above 
the peritoneal reflection) was resected, followed by end-to-end 
anastomosis of the resulting segment, in a single transmural plane, 
using continuous 6-0 polypropylene suture and a cylindrical 
needle. 
After anastomosis, in the animals in the sepsis group, 
abdominal sepsis was experimentally induced using the cecal 
ligation and puncture (CLP) method, as described by Rittirsch 
et al.9 – one half of the cecum was ligated using 3-0 silk thread 
(Shalon®). The end of the cecum, located distal to the ligation, was 
punctured at 10 random sites using an 18Gx1 1/2” (40x12mm) 
venipuncture needle, and some fecal content was extruded. The 
abdominal wall was closed in two planes with a simple running 
suture (3-0 silk thread). 
Animals that died within the first 24 postoperative hours 
were excluded from the study. Metamizole sodium monohydrate 
(20 mg/kg) was added to the animals’ water for analgesia until 
the day of euthanasia. No antibiotics were used. 
After the operations, metoclopramide was administered 
to animals in the experimental subgroups at a dose of 1 mg/100 
g, subcutaneously, every 12 hours until the animal was killed. 
Control animals received identical amounts of saline solution, 
subcutaneously, every 12 hours. 
Reoperation was performed on the scheduled day for 
each subgroup. After exposure, the abdominal cavity was assessed 
for anastomotic dehiscence. A 4.0-cm colonic segment, with the 
anastomosis at the center, was removed en bloc together with any 
adherent structures. 
Animals were killed with an overdose of sodium 
thiopental (150 mg/kg) administered directly into the inferior vena 
cava.
Specimen preparation
After resection of the adherent structures, specimens were 
opened at the antimesenteric border and divided into longitudinal 
sections for later analysis of the gene expression of MMP-1a, 
MMP-8, MMP-13, IL-1β, IL-6, IL-10, TNF-α, and interferon-γ 
(IFN-γ). 
The anastomotic segment was macerated in TRI Reagent® 
solution (Applied Biosystems, Foster City, CA, USA). RNA was 
isolated by a single extraction with a phenol-chloroform mixture 
and treated with Promega DNAse in the presence of an RNAse 
inhibitor (Promega, cat#M6101; Lot# 262753) in order to remove 
all traces of residual genomic DNA contamination, according 
to the protocol. Equal amounts of RNA (0.4 µg) were subjected 
to reverse transcription with High Capacity cDNA Reverse 
Transcription Kits (Applied Biosystems). 
Real-time quantitative reverse transcription polymerase 
chain reaction (qRT-PCR) was performed using a 7500 Fast Real-
Time PCR System (Applied Biosystems). Amplification of cDNA 
sequences was performed using the PCR Master Mix kit (Applied 
Biosystems) containing the SYBR® Green intercalating agent, a 
fluorescent molecule that intercalates into double-stranded DNA 
after initial denaturation at 95ºC for 15 seconds, followed by 60°C 
for 1 minute. 
To confirm amplification specificity, PCR products were 
analyzed by denaturation curves or melting curves. Comparisons 
were made using the threshold cycle (Ct) or crossing point (Cp)10 
method with cyclophilin to normalize values in order to assess 
the variation in fold-change expression of each gene. The fold-
change expression represents the ratio of the measured value for 
the treated animals to the value for the non-treated cohorts. Values 
greater than 2.0 were considered positively modulated, whereas 
values less than 0.5 were negatively modulated. We considered 
that there was no change in gene expression in the range between 
these values. Reactions were performed in triplicate for all genes 
analyzed. All oligonucleotide pairs were designed using the Primer 
Express® software (Applied Biosystems), and they are listed in 
Table 1. 
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TABLE 2 - Fold-change expression assessed on the 3rd and 7th postoperative days (metalloproteinases) in non-septic rats: 




NS3 39.96720 (±10.32386) 0.44079 (±0.08206) 5.12306 (±2.61933)
NS7 0.00135 (±0.00096) 0.00015 (±0.00004) 0.02294 (±0.02283)
MMP = matrix metalloproteinase; NS3 = non-septic rats receiving metoclopramide euthanized on the 3rd postoperative day; NS7 = non-septic rats receiving metoclo-
pramide euthanized on the 7th postoperative day. 
Results 
Effects of metoclopramide on non-septic rats 
There were no deaths in either group on the 3rd or 7th 
POD. There was no anastomotic dehiscence on the 3rd POD. 
On the 7th POD, one animal in the treated subgroup (NS7) had 
anastomotic dehiscence blocked by adjacent organs, which was 
noticed only after opening the surgical specimen.  
Administration of metoclopramide was associated with 
increased MMP-1a and MMP-13 expression on the 3rd POD. On 
the 7th POD, the transcripts of all MMPs of all treated animals 
became negatively modulated (Table 2).
On the 3rd POD, administration of metoclopramide 
positively modulated TNF-α gene expression and negatively 
modulated IL-6, IL-1β, and IL-10. On the 7th POD, negative 
modulation of TNF-α, IL-1β, IFN-γ and IL-10 was observed in all 
treated animals (Table 3).
TABLE 1 - Genes and oligonucleotides used in real-time quantitative reverse transcription polymerase chain reaction (qRT-
PCR).
Genes Oligos
Cyclophilin 5’ - TAT CTG CAC TGC CAA GAC TGA GTG - 3’ F
5’ - CTT CTT GCT GGT CTT GCC ATT CC - 3’ R
TNF-α 5’ - AAA TGG GCT CCC TCT CAT CAG TCC - 3’ F
5’ - TCT GCT TGG TGG TTT GCT ACG AC - 3’ R
IL-6 5’- TCC TAC CCC AAC TCC CAA TGC TC - 3’ F 
5’- TTG GAT GGT CTT GGT CCY YAG CC - 3’ R 
IL-1β 5’- CAC CTC TCA AGC AGA GCA CAG - 3’ F
5’- GGG TTG CAT GGT GAA GTC AAC - 3’ R
IL-10 5’- CAG ACC CAC ATG CTC CGA GA - 3’ F 
5’- CAA GGC TTG GCA ACC CAA GTA - 3’ R
IFN-γ 5’- GAT CCA GCA CAA AGC TGT CA - 3’ F
5’- GAC TCC TTT TCC GCT TCC TT- 3’ R
MMP-1a 5’- AGG AGC ACT AAT GTT CCC CAG CT - 3’ F
5’- TGG GAT TTG GGG AAG GCC CAT A - 3’ R
MMP-8 5’- GGA GTG TGC CAT CAA CCC TGA CC - 3’ F
5’- TGT CAC CAT GGT CTC TTG AGA CGA - 3’ R
MMP-13 5’- ACC CAG CCC TAT CCC TTG ATG CC - 3’ F
5’- GGT GCA GAC GCC AGA AGA ATC TGT - 3’ R
IFN = interferon; IL = interleukin; MMP = matrix metalloproteinase; TNF = tumor necrosis factor. 
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On the 3rd POD, administration of metoclopramide was 
associated with increased expression of TNF-α. In the same period, 
IL-6, IL-1β, IFN-γ and IL-10 gene expression were negatively 
modulated. On the 7th POD, treated animals had increased IFN-γ 
and IL-10 gene expression. TNF-α and IL-6 gene expression were 
negatively modulated (Table 5).
TABLE 3 - Fold-change expression assessed on the 3rd and 7th postoperative days (interleukins) in non-septic rats: treated 
animals vs. non-treated cohorts.
Subgroup
Gene
TNF-α IL-6 IL-1β IFN-γ IL-10
NS3 39.61586 (±11.90558) 0.13742(±0.08054) 0.02908 (±0.01590) 1.12636 (±0.57227) 0.02161(±0.00937)
NS7 0.41796 (±0.18294) 0.55071 (±0.75599) 0.00272 (±0.00219) 0.38569 (±0.32737) 0.00826(±0.00817)
IFN = interferon; IL = interleukin; TNF = tumor necrosis factor; NS3 = non-septic rats receiving metoclopramide euthanized on the 3rd postoperative day; NS7 = non-
septic rats receiving metoclopramide euthanized on the 7th postoperative day. 
TABLE 4 - Fold-change expression assessed on the 3rd and 7th postoperative days (metalloproteinases) in septic rats: treated 




SS3 1.92786 (±1.13530) 1.99820 (±0.20220) 1.87653 (±0.32977)
SS7 3.39068 (±0.37667) 4.78554 (±2.66097) 2.28274 (±1.82443)
MMP = matrix metalloproteinase; SS3 = septic rats receiving metoclopramide euthanized on the 3rd postoperative day; SS7 = septic rats receiving metoclopramide 
euthanized on the 7th postoperative day. 























IFN = interferon; IL = interleukin; TNF = tumor necrosis factor; SS3 = septic rats receiving metoclopramide euthanized on the 3rd postoperative day; SS7 = septic rats 
receiving metoclopramide euthanized on the 7th postoperative day.
Effects of metoclopramide on septic rats 
There were no deaths in the group killed on the 3rd POD. 
There was one death in each subgroup of septic animals scheduled 
to be killed on the 7th POD. None of the deaths was related to 
anastomotic dehiscence. 
On the 3rd POD, one animal in the non-treated subgroup 
(SC3) had free anastomotic dehiscence. On the 7th POD, one 
animal in each subgroup (SC7 e SS7) had anastomotic dehiscence 
blocked by adjacent organs, which was noticed only after opening 
the surgical specimen.  
On the 3rd POD, administration of metoclopramide did 
not change MMP gene expression; however, increased expression 
of all MMPs was observed on the 7th POD (Table 4).
Discussion 
The colon is the site of the gastrointestinal tract most 
vulnerable to anastomotic leakage. High mortality and severe 
morbidity associated with dehiscence support the need for further 
research into the evaluation of the deleterious effects of drugs and 
infection on wound healing.  
Metoclopramide is a prokinetic agent often used in 
the postoperative period after colorectal surgery, and the CLP 
method is one of the most commonly used models to study 
Effects of metoclopramide on the expression of metalloproteinases and 
interleukins in left colonic anastomoses. An experimental study
Acta Cirúrgica Brasileira - Vol. 30 (11) 2015 - 767
the pathophysiology of abdominal sepsis and its systemic 
consequences11. 
The expression of most MMPs is transcriptionally 
regulated by growth factors, hormones, cytokines, and cell 
transformation. MMPs are secreted into the extracellular 
environment as zymogens or pro-MMPs on demand, except in 
the case of neutrophils, macrophages, and Paneth’s cells, in which 
MMPs are stored in granules12. They are involved in many different 
and fundamental biological processes, such as coagulation, 
immunity, inflammation, angiogenesis, tissue removal, connective 
tissue remodeling, and epithelial cell and fibroblast migration12,13. 
Under normal conditions, the expression of MMPs is 
restricted to a few tissues which show intense remodeling, such 
as the endometrium during the menstrual cycle, healing wounds, 
and tissues undergoing inflammatory reaction13. Therefore, MMPs 
are absent in normal colon but can be seen in the suture line after 
anastomosis.  
Controlling the activity of MMPs is essential to prevent 
excessive breakdown, which may result in anastomotic dehiscence 
and its associated increase in morbidity and mortality, or 
insufficient breakdown, which may result in fibrosis and stricture 
formation14. Patients with increased MMP-1, MMP-2 and MMP-9 
in perioperative colonic biopsies have shown increased rates of 
anastomotic dehiscence15. Furthermore, the inhibition of MMP 
activity has enhanced the healing of colonic anastomoses, with 
higher burst pressure and increased amount of collagen fibers in 
the submucosal layer at the anastomotic site16.  
It has been suggested that matrix degradation may be 
increased by unspecified mechanisms during bacterial peritonitis17. 
The origin of the increased MMP level in healing anastomoses 
during peritonitis remains a matter of speculation and may be 
due to an increased number of inflammatory cells present close 
to the healing anastomosis during infectious processes, such as 
polymorphonuclear cells, macrophages, and monocytes17.  
In previous studies, we found that metoclopramide had no 
harmful effects on the healing of intestinal anastomoses in rats in 
the presence18 or absence19 of abdominal sepsis after tensile strength 
testing, measurement of hydroxyproline levels, histomorphometric 
evaluation of collagen, and histopathological analysis. Although 
the difference was not statistically significant, we noted that, in the 
absence of peritoneal sepsis, the anastomoses of metoclopramide-
treated animals had lower anastomotic breaking strength on the 
3rd POD and higher values on the 7th POD, compared to saline 
solution-treated controls19. This might be explained in the present 
study by the increased expression of MMP-1a and MMP-13 on 
the 3rd POD and the subsequent negative modulation of all MMPs 
on the 7th POD in the anastomoses of all metoclopramide-treated 
animals.  
Under septic conditions, our previous study showed 
no statistical difference across groups in the rates of tensile 
strength neither on the 3rd nor on the 7th POD18. In the present 
study, under septic conditions, on the 3rd POD administration of 
metoclopramide did not change MMP gene expression, but on the 
7th POD we could observe an increased expression of all MMPs. 
In spite of that, there was no evidence of a greater number of 
anastomotic leaks in the treated group.  
In a previous study, in which we investigated the isolated 
effect of CLP-induced abdominal sepsis on anastomotic healing, 
we found that, in the absence of drug administration, infection 
reduced the breaking strength of left colonic anastomoses on the 
3rd POD, but enhanced values were observed on the 7th POD20. 
Abdominal sepsis was associated with increased MMP-1a gene 
expression and reduced MMP-8 gene expression both on the 3rd 
and 7th POD. There was no change in MMP-13 gene expression21. 
Nevertheless, it is important to point out that the study 
of MMP activity by immunohistochemical staining or mRNA 
analysis does not necessarily mean that matrix degradation will 
occur, since strict control of MMP activity is preserved when 
MMPs are released as inactive pro-enzymes or by the presence of 
inhibitors22.  
After trauma, cytokines are primarily synthesized 
and released at the site of injury and subsequently released 
systemically5. IL-1β is the first warning sign of adjacent cells after 
tissue damage23. It induces secretion of IFN-γ, IL-6, and MMPs24. 
TNF-α is an inflammatory mediator that plays an active role in 
collagen synthesis and also provides metabolic substrate for 
wound healing during the inflammatory phase25. Increased TNF-α 
levels after 24 hours are correlated with delayed healing6.  
IL-6 plays an active role in modulating proliferation, 
differentiation and maturation of several cell types7. Studies 
have reported increased IL-6 and TNF-α levels in patients 
with postoperative complications26. IFN-γ is involved in the 
inflammatory response that involves immune pathways. IL-10 is 
one of the most widely known negative markers of inflammation27. 
This cytokine increases 24 hours after surgical procedures, 
reducing pro-inflammatory cytokines, such as TNF-α and IL-66.  
Many authors have studied the variation in cytokine levels 
in the postoperative period and the occurrence of complications5. 
Herwig et al.4 showed that a marked increase in IL-6 and TNF-α 
levels may be considered a precursor event occurring days before 
the secondary clinical signs of anastomotic leakage and that the 
increase in IL-1β cytokine levels became statistically significant 
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on the 3rd POD in patients who had anastomotic dehiscence. Also, 
a positive correlation has been described between IL-1β, IL-6 
and TNF-α levels and prolonged operative time, blood loss and 
bacterial contamination of peritoneal fluid28. 
In our previous study21, the anastomoses of animals 
subjected to CLP showed negative modulation of IL-6, IL-1β and 
IFN-γ gene expression both on the 3rd and 7th POD. There was an 
increase in the gene expression of TNF-α only on the 7th POD and 
of IL-10 on the 3rd POD.  
Some authors, investigating the effects of metoclopramide 
administration on cytokine release in mixed splenocyte cultures 
in CLP or sham-operated mice, noticed no effects on untreated 
or sham-operated groups, but sepsis was associated with a 
significantly decrease in IL-6 and IFN-γ release. Administration 
of metoclopramide in septic mice normalized the release of IL-6 
and IFN-γ29. 
In the present study, on the 3rd POD, administration 
of metoclopramide positively modulated TNF-α and negatively 
modulated IL-6, IL-1β and IL-10 gene expression both in the 
presence and absence of abdominal sepsis. On the 7th POD, 
metoclopramide-treated animals showed negative modulation of 
TNF-α in both septic and non-septic conditions, but had increased 
IFN-γ and IL-10 gene expression in the presence of abdominal 
sepsis. 
However, it is important to highlight that the detection 
of cytokine gene expression or even cytokine levels in tissues 
or secretions does not necessarily correlate with its biological 
activity. Cytokines may not have been produced, but rather may 
have been released as inactive pro-enzymes or may have already 
been degraded30. 
Conclusions 
Administration of metoclopramide increased MMP and 
IL gene expression on the 3rd POD and negatively modulated 
them on the 7th POD. In the presence of abdominal sepsis, 
metoclopramide did not change MMPs and decreased ILs gene 
expression on the 3rd POD. On the 7th POD, the drug increased 
expression of all MMPs and negatively modulated TNF-α and 
IL-6 gene expression.
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